ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in September 2024. Updated September 30.
A roundup of FDA’s actions in September 2024.
FDA Output, September 2024
×
